Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: November 2012

Synacor, Inc. (SYNC) Appoints Cloud Software Expert Steve Davi as Senior Vice President, Software Engineering

Synacor, leading provider of next-gen startpages, TV Everywhere solutions, and cloud-based services across multiple devices for cable, satellite, telecom, and consumer electronics companies, today announced that Steve Davi has been appointed as senior vice president, software engineering. Prior to Synacor, … Continue reading

Posted in Small Cap News | Leave a comment

CRAiLAR Technologies, Inc. (CL) to Begin Construction on Full-Scale Manufacturing Facility

CRAiLAR Technologies confirmed that it will begin construction on its first full-scale manufacturing facility for CRAiLAR Flax Fiber on December 17, 2012. Production of its sustainable, performance-driven flax fiber is expected to keep the same timeframe as originally stated at … Continue reading

Posted in Small Cap News | Leave a comment

Envivio, Inc. (ENVI) Solution Deployed by LG U+ for First Korean Google TV Service

Envivio, a prominent supplier of live and on-demand multi-screen IP video processing and delivery solutions, announced that Envivio encoding solutions have been deployed by LG U+ to power its new LG u+tv G multi-screen service. This service is the first … Continue reading

Posted in Small Cap News | Leave a comment

Calpian, Inc. (CLPI) Securing Payment Processing Industry Territory Through Better Rates, More Efficient Services, and Shrewd Marketing

Calpian has positioned itself as a vital connection in the ecosystem created between large processors and end market merchants by developing an array of electronic payment processing solutions which allow for exemplary streamlining of the overall transaction event structure, rendering … Continue reading

Posted in Small Cap News | Leave a comment

Teva Pharmaceuticals, Inc. (TEVA) Increasing Ownership in Rexahn Pharmaceuticals (RNN)

Rexahn Pharmaceuticals is a clinical-stage pharmaceutical company focused on developing and commercializing first-in-class, market-leading therapeutics for cancer, central nervous disorders, sexual dysfunction, and other unmet medical needs. The company currently has three drug candidates in Phase II clinical trials – … Continue reading

Posted in Small Cap News | Leave a comment

Cardium Therapeutics, Inc. (CXM) Moving Rapidly with Excellagen

Excellagen, Cardium’s FDA-cleared highly-refined fibrillar collagen-based topical gel designed to facilitate wound care management for diabetic ulcers and many other types of wounds, has been the center of much of Cardium’s recent activity. The product was selected by Podiatry Today, … Continue reading

Posted in Cardium Therapeutics Inc. CXM | Leave a comment

MRI Interventions, Inc. (MRIC) Awarded Frost & Sullivan 2012 Global Company of the Year Award

Commercial stage medical device company MRI Interventions was recognized for its innovative platforms and technologies by receiving the 2012 Global Company of the Year Award in Image-Guided Neural Interventions by Frost & Sullivan, a global business research and consulting firm. … Continue reading

Posted in Small Cap News | Leave a comment

Meru Networks, Inc. (MERU) to Award Top Channel Partners in 2013

Meru Networks recently announced that the company is introducing a new channel program that intends to recognize and reward its top partners, such as resellers and systems integrators. Among the benefits include an incentives program and no-cost training. Sunnyvale, CA-based … Continue reading

Posted in Small Cap News | Leave a comment

Avanir Pharmaceuticals (AVNR) Pre-Announces Preliminary Results for Fiscal 2012 Fourth Quarter, Provides Update on AVP-786 Clinical Study

Avanir Pharmaceuticals yesterday announced preliminary results for the quarter ended Sept. 30, 2012. The company estimates fourth fiscal quarter gross revenue to be $15.4 million, which represents an increase of around 26 percent from the previous quarter. The company’s total … Continue reading

Posted in Small Cap News | Leave a comment

Vermillion, Inc. (VRML) Appoints Bruce Huebner as Interim CEO

Vermillion, a molecular diagnostics company, announced that director Bruce A. Huebner has been appointed as interim CEO. He is following Gail S. Page, the company’s most recent CEO, who will assist in the transition and serve as a strategic advisor. … Continue reading

Posted in Small Cap News | Leave a comment